Q&A: Infectious Diseases Expert Talks Vaccines and COVID-19
6/29/2020
As the COVID-19 pandemic continues its spread, harming and hampering lives and economies, one thing is clear: we need a vaccine. Dr. Steven Zeichner, a University of Virginia infectious diseases…
Exercise May Offer ‘Profound’ Benefits For Friedreich’s Ataxia, Research Suggests
6/16/2020
A top exercise researcher at the University of Virginia School of Medicine is urging clinical trials of exercise in patients with Friedreich’s ataxia after finding that physical activity has a “profound” protective…
Diet, Gut Microbes Affect Effectiveness of Cancer Treatment, Research Reveals
6/16/2020
Eyleen O’Rourke, UVA assistant professor of biology, says that by modulating the microbes that live in our gut, there is enormous potential to improve treatment outcomes. What we eat can…
In Victory Over Polio, Hope for the Battle Against COVID-19
5/18/2020
UVA Health's Bill Petri, MD, PhD, is developing a vaccine for COVID-19. For much of the 20th century, summer was “polio season,” and people were accustomed to seeing swimming pools…
COVID-19: UVA Discovery Spurs Clinical Trial Of Antidepressant To Fight Virus
5/13/2020
An antidepressant medication is being tested as a potential treatment for COVID-19 after University of Virginia School of Medicine researchers determined it may prevent dangerous overreactions by the immune system. Researchers…
Spinal Cord Injuries: UVA Scientists Probe Individual Cells To Find Better Treatments
4/30/2020
Two top scientists at the University of Virginia School of Medicine are seeking answers to questions about spinal cord injuries that have long frustrated the development of effective treatments. The scientists,…
Brain Discovery Suggests Source of Lifelong Behavioral Issues
4/20/2020
"When the damage isn’t recognized, the cells that have DNA damage live on in the CNS [central nervous system] and can be seen by accumulation of DNA damage in the…
UVA Identifies Surprising Contributor to Multiple Sclerosis
10/10/2019
Cells that scientists have largely ignored when studying multiple sclerosis are actually key contributors to MS development, new research from the University of Virginia School of Medicine shows. The discovery suggests…
UVA Professor’s Promising Cancer Drug Attracts $25 Million in Funding
10/3/2019
UVA biomedical engineering professor Kimberly Kelly founded ZielBio to bring new cancer treatments to market. (Photo by Dan Addison, University Communications) In her previous post as an assistant professor at…
Pancreatic Cancer Discovery Reveals How the Aggressive Cancer Fuels its Growth
9/27/2019
A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work – and for whom they…
